CBLL
CeriBell·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CBLL
Ceribell, Inc.
A commercial medical technology company focused on changing the diagnosis and management of patients with severe neurological disorders
Healthcare Technology
08/29/2014
10/11/2024
NASDAQ Stock Exchange
281
12-31
Common stock
360 N. Pastoria Avenue, Sunnyvale, California 94085
--
CeriBell, Inc., was incorporated in Delaware on August 29, 2014. They are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with severe neurological diseases. They developed the Ceribell System, a novel point-of-care electroencephalography (" EEG ") platform specifically designed to address the unmet needs of patients in acute care settings. The Ceribell system combines proprietary, highly portable, rapidly deployable hardware with sophisticated artificial intelligence (" AI ") -driven algorithms to enable rapid diagnosis and continuous monitoring of patients with neurological diseases. The Ceribell system makes EEG more accessible and enables continuous monitoring through the power of artificial intelligence, enabling clinicians to diagnose and manage patients at risk of seizures faster and more accurately in acute care settings, thereby improving patient outcomes and economic benefits for hospitals and payers.
Earnings Call
Q2/2025
Estimate EPS-0.4
Actual EPS-0.38
Estimate Revenue20.45M
Actual Revenue21.20M
CeriBell, Inc.'s Q2 2025 Earnings: Unpacking Contradictions on Margins, Market Expansion, and Growth Strategy
Aug 05,2025 11:51
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS-0.41
Actual EPS0.37
Estimate Revenue21.78M
Actual Revenue22.60M
Ceribell's Q3 2025 Earnings Call: Key Contradictions in Utilization Growth, Sales Strategy, and Gross Margin Projections
Nov 04,2025 07:06
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
CBLL has released its 2025 Q3 earnings. EPS was reported at 0.37, versus the expected -0.41, beating expectations. The chart below visualizes how CBLL has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CBLL has released its 2025 Q3 earnings report, with revenue of 22.59M, reflecting a YoY change of 31.37%, and net profit of -13.46M, showing a YoY change of -29.26%. The Sankey diagram below clearly presents CBLL's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
